PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43 | -99.8% | 145 | -99.3% | 0.00% | – |
| Q1 2023 | $21,710 | -99.4% | 22,243 | -99.4% | 0.00% | – |
| Q4 2022 | $3,812,295 | +523.9% | 3,665,668 | +589.3% | 0.00% | – |
| Q3 2022 | $611,000 | -42.2% | 531,830 | -5.9% | 0.00% | – |
| Q2 2022 | $1,057,000 | -39.2% | 565,268 | -1.5% | 0.00% | – |
| Q1 2022 | $1,738,000 | +7.7% | 573,839 | +34.4% | 0.00% | – |
| Q4 2021 | $1,614,000 | +2682.8% | 427,100 | +3668.6% | 0.00% | – |
| Q3 2021 | $58,000 | -6.5% | 11,333 | -30.3% | 0.00% | – |
| Q2 2021 | $62,000 | -66.7% | 16,266 | -77.4% | 0.00% | – |
| Q1 2021 | $186,000 | +67.6% | 72,090 | +63.1% | 0.00% | – |
| Q4 2020 | $111,000 | -80.7% | 44,197 | -84.1% | 0.00% | – |
| Q3 2020 | $576,000 | +711.3% | 278,285 | +1131.2% | 0.00% | – |
| Q2 2020 | $71,000 | +61.4% | 22,603 | +17.7% | 0.00% | – |
| Q1 2020 | $44,000 | -65.6% | 19,204 | -45.6% | 0.00% | – |
| Q4 2019 | $128,000 | +47.1% | 35,275 | +36.8% | 0.00% | – |
| Q3 2019 | $87,000 | -57.8% | 25,792 | -41.1% | 0.00% | – |
| Q2 2019 | $206,000 | -81.0% | 43,814 | -86.4% | 0.00% | – |
| Q1 2019 | $1,082,000 | +46.4% | 323,135 | +16.5% | 0.00% | – |
| Q4 2018 | $739,000 | +324.7% | 277,370 | +793.1% | 0.00% | – |
| Q3 2018 | $174,000 | +46.2% | 31,058 | +31.5% | 0.00% | – |
| Q2 2018 | $119,000 | -19.0% | 23,614 | +9.9% | 0.00% | – |
| Q1 2018 | $147,000 | +18.5% | 21,493 | +30.5% | 0.00% | – |
| Q4 2017 | $124,000 | +47.6% | 16,464 | +12.9% | 0.00% | – |
| Q3 2017 | $84,000 | +1.2% | 14,588 | -11.6% | 0.00% | – |
| Q2 2017 | $83,000 | +80.4% | 16,500 | -5.7% | 0.00% | – |
| Q1 2017 | $46,000 | +84.0% | 17,500 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | -21.9% | 17,500 | 0.0% | 0.00% | – |
| Q3 2016 | $32,000 | +33.3% | 17,500 | +16.7% | 0.00% | – |
| Q2 2016 | $24,000 | +26.3% | 15,000 | +50.0% | 0.00% | – |
| Q1 2016 | $19,000 | -17.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $23,000 | +27.8% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |